VVUS : Summary for VIVUS, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 58 mins

VIVUS, Inc. (VVUS)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.39-0.01 (-0.71%)
As of 11:01 AM EST. Market open.
People also watch:
OREXARNAKERXAMRNXOMA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.40
Open1.42
Bid1.39 x 3600
Ask1.40 x 1000
Day's Range1.36 - 1.42
52 Week Range0.92 - 1.85
Volume238,316
Avg. Volume470,125
Market Cap145.73M
Beta0.50
PE Ratio (TTM)-3.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session
    Zacks14 days ago

    VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session

    VIVUS Inc. (VVUS) moved big last session, as its shares jumped a little more than 5% on the day.

  • Capital Cube17 days ago

    ETFs with exposure to VIVUS, Inc. : November 18, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to VIVUS, Inc. Here are 5 ETFs with the largest exposure to VVUS-US. Comparing the performance and risk of VIVUS, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • VIVUS, Inc. :VVUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube21 days ago

    VIVUS, Inc. :VVUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis VIVUS, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of VIVUS, Inc. – Orexigen Therapeutics, Inc., Apricus Biosciences, Inc., Pfizer Inc., AmerisourceBergen Corporation, Eli Lilly and Company, Cardinal Health, Inc., Repros Therapeutics Inc. and Arena Pharmaceuticals, Inc. (OREX-US, APRI-US, ... Read more (Read more...)